Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 33408
Event :6th Microbiome Movement - Drug Development Summit Europe

Dates :Tuesday January 25th, 2022 - Thursday January 27th, 2022

Location :Online (Internet, Videoconferencing, ...)

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
 
The 6th Microbiome Movement – Drug Development Summit Europe will return online to unite leading scientists and industry partners surrounding the microbiome to pursue the causal role of the microbiome in disease, with the aim to obtain the first EMA-approved microbiome-targeted therapeutic from predictable modes of action and consistent clinical outcomes. Join us to explore the progress made in the last 12 months, and uncover where this microbiome space is heading!
 
Group discounts and early booking rates are available. Please visit the website for full pricing information.
 
Website https://go.evvnt.com/919896-0?pid=4319
Tickets https://go.evvnt.com/919896-2?pid=4319
Brochure https://go.evvnt.com/919896-3?pid=4319
 
Prices:
Drug Developer - Conference Only (digital) GBP 1549.00
Academic - Conference Only (digital) GBP 1299.00
Solution & Service Provider - Conference Only (digital) GBP 1899.00
 
Speakers: Charles Bundinof, Strain Discovery and Microbiome Science Lead, IFF, Denise Kelly, Investment Advisor, Seventure, Duncan Peyton, CEO, 4D Pharma PLC, Hervé Affagard, CEO, MaaT Pharma, John Hambor, Director, Research Beyond Borders, Boehringer Ingleheim, Kristin Wannerberger, Director R&D Alliance Management, Ferring, Mike Ramonas, CEO, Microbiotica, Yogesh Mudaliar, Global Millennial Advisory Board Member CEO, Takeda, Sonia Timberlake, Senior Vice President, Finch, Shiri Meshner, VP R&D, Biomica LtD, Tomas de Wouters, Co-founder and CEO, PharmaBiome, Barbara McGovern, M. D. VP Medical Affairs, Seres Therapeutics, Celine Druart, Pharmabiotic Research Institute, Microbiome Project Manager, Paul Carlson, Principal Investigator, FDA, Anders Damholt, Head of Clinical Development, Chr. Hansen, Adam Wilkinson, Pre-Clinical Development, Microbiotica
 
Date and Time: Starts: Tue, Jan 25, 2022 (10:00 AM) and Ends: Thu, Jan 27, 2022 ( 5:50 PM)

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

6th Microbiome Movement - Drug Development Summit Europe Medicine
microbiome, drugdevelopment, biomarker, clinicaldata, diagnosticdevelopment, microbiome-basedtherapeutics, biopharmaceuticaltreatment, biopharmaceutical
Everyone
-- -- --
English

Recommend this event